AMED Historical Earnings image   This AMED historical earnings page last updated 7/29/2022
AMED Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20227/27/20220.56B
Q1 20224/27/20220.55B
Q4 20212/23/20220.56B
Q3 202111/2/20210.55B
Q2 20218/4/20210.56B
Q1 20214/28/20210.54B
Q4 20202/24/20210.55B
Q3 202010/28/20200.54B
Q2 20207/28/20200.49B
Q1 20205/6/20200.49B
Q4 20192/18/20200.50B
Q3 201910/29/20190.49B
Q2 20197/31/20190.49B
Q1 20194/30/20190.47B
Q4 20182/27/2019434.38M
Q3 201810/29/2018417.33M
Q2 20187/31/2018411.60M
Q1 20185/7/2018399.26M
Q4 20172/27/2018404.24M
Q3 201711/7/2017380.16M
Q2 20177/26/2017378.82M
Q1 20175/2/2017370.46M
Q4 20162/28/2017365.15M
Q3 201611/3/2016361.60M
Q2 20168/2/2016361.69M
Q1 20165/3/2016348.82M
Q4 20153/9/2016337.31M
Q3 201511/5/2015326.45M
Q2 20157/29/2015314.15M
Q1 20154/29/2015301.57M
Q4 20143/4/2015300.53M
Q3 201410/29/2014300.28M
Q2 20147/30/2014243.50M
Q1 20145/8/2014298.74M
Q4 20133/12/2014303.49M
Q3 201311/12/2013301.64M
Q2 20137/31/2013313.15M
Q1 20134/30/2013273.60M
Q4 20123/12/2013362.90M
Q3 201211/6/2012375.60M
AMED Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20227/27/20221.470
Q1 20224/27/20221.230
Q4 20212/23/20221.180
Q3 202111/2/20211.530
Q2 20218/4/20211.690
Q1 20214/28/20211.540
Q4 20202/24/20211.490
Q3 202010/28/20202.240
Q2 20207/28/20201.340
Q1 20205/6/20201.050
Q4 20192/18/20200.940
Q3 201910/29/20191.150
Q2 20197/31/20191.210
Q1 20194/30/20191.110
Q4 20182/27/20190.91
Q3 201810/29/20180.95
Q2 20187/31/20181
Q1 20185/7/20180.79
Q4 20172/27/20180.56
Q3 201711/7/20170.56
Q2 20177/26/20170.62
Q1 20175/2/20170.47
Q4 20162/28/20170.44
Q3 201611/3/20160.36
Q2 20168/2/20160.42
Q1 20165/3/20160.33
Q4 20153/9/20160.4
Q3 201511/5/20150.34
Q2 20157/29/20150.43
Q1 20154/29/20150.3
Q4 20143/4/20150.27
Q3 201410/29/20140.28
Q2 20147/30/20140.23
Q1 20145/8/2014-0.07
Q4 20133/12/2014-0.07
Q3 201311/12/2013-0.01
Q2 20137/31/20130.17
Q1 20134/30/20130.13
Q4 20123/12/20130.23
Q3 201211/6/20120.33
Quotes delayed 20 minutes

Email EnvelopeFree AMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Amedisys (AMED) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AMEH Historical Earnings
AMGN Historical Earnings
AMN Historical Earnings
AMPH Historical Earnings
AMRX Historical Earnings
AMTI Historical Earnings
ANAB Historical Earnings
ANGN Historical Earnings
ANGO Historical Earnings
ANIK Historical Earnings
What was the record high AMED historical earnings result?
In terms of earnings or revenue, what is the best AMED historical earnings result that Amedisys has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AMED historical earnings result was set in Q3 2020, when Amedisys posted results of 2.240/share. The most successful revenue quarter within our data set was Q2 2021 when Amedisys reported revenue of 0.56B.

What was the lowest Amedisys historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AMED has reported, and when?

✔️Accepted answer: Within our data set, the lowest AMED historical earnings result was set in Q1 2014, when Amedisys posted results of -0.07/share. The smallest revenue quarter within our data set was Q2 2014 when Amedisys reported revenue of 243.50M.

On this page we presented the AMED historical earnings date information for Amedisys. Reviewing that AMED Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2020, when AMED posted adjusted EPS of 2.240/share. Meanwhile the lowest AMED historical earnings result was in Q1 2014, when AMED posted adjusted EPS of -0.07/share. Moving to Amedisyss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2021 when AMED reported 0.56B in revenue, while the smallest revenue quarter was Q2 2014 when AMED reported 243.50M in revenue.

For self directed investors doing their due diligence on AMED or any other given stock, their research can benefit from looking into all of the Amedisys historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Amedisys historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AMED. Thanks for visiting, and the next time you need to research AMED historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: AXDX Price Target, ETFs Holding MCRI, Funds Holding KLA.

 

AMED Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.